These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20178069)

  • 1. Variability in duration of outpatient diuretic therapy in bronchopulmonary dysplasia: a clinical experience.
    Bhandari A; Chow U; Hagadorn JI
    Am J Perinatol; 2010 Aug; 27(7):529-35. PubMed ID: 20178069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants.
    Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL;
    J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic hypertension in infants with severe bronchopulmonary dysplasia: associated clinical factors.
    Anderson AH; Warady BA; Daily DK; Johnson JA; Thomas MK
    Am J Perinatol; 1993 May; 10(3):190-3. PubMed ID: 8517893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial.
    Kao LC; Warburton D; Cheng MH; Cedeño C; Platzker AC; Keens TG
    Pediatrics; 1984 Jul; 74(1):37-44. PubMed ID: 6377221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to oxygen and head growth in infants with bronchopulmonary dysplasia.
    Nesterenko TH; Nolan B; Hammad TA; Aly H
    Am J Perinatol; 2008 Apr; 25(4):251-4. PubMed ID: 18548401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia.
    Slaughter JL; Stenger MR; Reagan PB
    Pediatrics; 2013 Apr; 131(4):716-23. PubMed ID: 23478874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of infants with bronchopulmonary dysplasia in North America.
    Bancalari E; Wilson-Costello D; Iben SC
    Early Hum Dev; 2005 Feb; 81(2):171-9. PubMed ID: 15748972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretics, hypochloremia, and outcome in bronchopulmonary dysplasia patients.
    Giacoia GP; Pineda R
    Dev Pharmacol Ther; 1991; 16(4):212-20. PubMed ID: 1782839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of introduction of synchronized nasal intermittent positive-pressure ventilation in a neonatal intensive care unit on bronchopulmonary dysplasia and growth in preterm infants.
    Kulkarni A; Ehrenkranz RA; Bhandari V
    Am J Perinatol; 2006 May; 23(4):233-40. PubMed ID: 16625501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic hypertension in very low-birth weight infants with bronchopulmonary dysplasia: incidence and risk factors.
    Alagappan A; Malloy MH
    Am J Perinatol; 1998 Jan; 15(1):3-8. PubMed ID: 9475679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a short course of prednisolone in infants with oxygen-dependent bronchopulmonary dysplasia.
    Bhandari A; Schramm CM; Kimble C; Pappagallo M; Hussain N
    Pediatrics; 2008 Feb; 121(2):e344-9. PubMed ID: 18245407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition and outpatient management of the very low-birth-weight infant with bronchopulmonary dysplasia.
    Groothuis JR; Makari D
    Adv Ther; 2012 Apr; 29(4):297-311. PubMed ID: 22529025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Colonisation of the airways with ureaplasma urealyticum as a risk factor for bronchopulmonary dysplasia in VLBW infants?].
    Ruf B; Klauwer D; Reiss I; Schiefer HG; Gortner L
    Z Geburtshilfe Neonatol; 2002; 206(5):187-92. PubMed ID: 12395292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence and risk factors of bronchopulmonary dysplasia among extremely low birth weight newborns of regional birth cohort of south-east Poland].
    Kwinta P; Grudzień A; Pawlik D; Olechowski W; Lauterbach R; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):14-20. PubMed ID: 19485250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the new definition of bronchopulmonary dysplasia more useful?
    Sahni R; Ammari A; Suri MS; Milisavljevic V; Ohira-Kist K; Wung JT; Polin RA
    J Perinatol; 2005 Jan; 25(1):41-6. PubMed ID: 15538399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study.
    Geary C; Caskey M; Fonseca R; Malloy M
    Pediatrics; 2008 Jan; 121(1):89-96. PubMed ID: 18166561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home oxygen therapy after preterm birth in Western Australia.
    Saletti A; Stick S; Doherty D; Simmer K
    J Paediatr Child Health; 2004; 40(9-10):519-23. PubMed ID: 15367144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged dexamethasone therapy reduces the incidence of cryotherapy for retinopathy of prematurity in infants of less than 1 kilogram birth weight with bronchopulmonary dysplasia.
    Sobel DB; Philip AG
    Pediatrics; 1992 Oct; 90(4):529-33. PubMed ID: 1408504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia.
    Kao LC; Durand DJ; McCrea RC; Birch M; Powers RJ; Nickerson BG
    J Pediatr; 1994 May; 124(5 Pt 1):772-81. PubMed ID: 8176568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia.
    Smith VC; Zupancic JA; McCormick MC; Croen LA; Greene J; Escobar GJ; Richardson DK
    J Pediatr; 2004 Jun; 144(6):799-803. PubMed ID: 15192629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.